Pilot Study of FFP104 Dose Escalation in PBC Subjects
NCT02193360
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Biliary Cirrhosis
Interventions
DRUG:
FFP104
Sponsor
Fast Forward Pharmaceuticals